For the first time, an in vivo experiment has established a positive combined (angiogenic and antinociceptive) effect of using the domestic genetically engineered construction pcDNA_VEGF165 under conditions of simulated limb muscle ischemia. A plasmid with a gene encoding the protein VEGF165 (pcDNA_VEGF165) may be the basis for creating the first gene therapy drugs in the Republic of Belarus.
No takes yet. Share an insight, caveat, or question.
Bogdan et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: